Biomarkers of Inflammation in Left Ventricular Diastolic Dysfunction
Open Access
- 2 June 2019
- journal article
- review article
- Published by Hindawi Limited in Disease Markers
- Vol. 2019, 1-14
- https://doi.org/10.1155/2019/7583690
Abstract
Left ventricular diastolic dysfunction (LVDD) is an important precursor to many different cardiovascular diseases. Diastolic abnormalities have been studied extensively in the past decade, and it has been confirmed that one of the mechanisms leading to heart failure is a chronic, low-grade inflammatory reaction. The triggers are classical cardiovascular risk factors, grouped under the name of metabolic syndrome (MetS), or other systemic diseases that have an inflammatory substrate such as chronic obstructive pulmonary disease. The triggers could induce myocardial apoptosis and reduce ventricular wall compliance through the release of cytokines by multiple pathways such as (1) immune reaction, (2) prolonged cell hypoxemia, or (3) excessive activation of neuroendocrine and autonomic nerve function disorder. The systemic proinflammatory state causes coronary microvascular endothelial inflammation which reduces nitric oxide bioavailability, cyclic guanosine monophosphate content, and protein kinase G (PKG) activity in adjacent cardiomyocytes favoring hypertrophy development and increases resting tension. So far, it has been found that inflammatory cytokines associated with the heart failure mechanism include TNF-α, IL-6, IL-8, IL-10, IL-1α, IL-1β, IL-2, TGF-β, and IFN-γ. Some of them could be used as diagnosis biomarkers. The present review aims at discussing the inflammatory mechanisms behind diastolic dysfunction and their triggering conditions, cytokines, and possible future inflammatory biomarkers useful for diagnosis.Keywords
This publication has 107 references indexed in Scilit:
- Tetrahydrobiopterin improves diastolic dysfunction by reversing changes in myofilament propertiesJournal of Molecular and Cellular Cardiology, 2013
- Pentraxin 3—a marker of diastolic dysfunction and HF?Nature Reviews Cardiology, 2011
- Usefulness of Soluble Concentrations of Interleukin Family Member ST2 as Predictor of Mortality in Patients With Acutely Decompensated Heart Failure Relative to Left Ventricular Ejection FractionThe American Journal of Cardiology, 2011
- The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fractionEuropean Journal of Heart Failure, 2010
- Interleukin 6 Mediates Myocardial Fibrosis, Concentric Hypertrophy, and Diastolic Dysfunction in RatsHypertension, 2010
- Galectin‐3, cardiac structure and function, and long‐term mortality in patients with acutely decompensated heart failureEuropean Journal of Heart Failure, 2010
- Uncoupled Cardiac Nitric Oxide Synthase Mediates Diastolic DysfunctionCirculation, 2010
- Nonmyocardial Production of ST2 Protein in Human Hypertrophy and Failure Is Related to Diastolic LoadJournal of the American College of Cardiology, 2008
- Tumor Necrosis Factor-α and Mortality in Heart FailureCirculation, 2008
- Monocyte Chemoattractant Protein-1 Induces a Novel Transcription Factor That Causes Cardiac Myocyte Apoptosis and Ventricular DysfunctionCirculation Research, 2006